chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: HPV9
Symptoms: Erythema, Pruritus, Rash, Skin warm, Urticaria
Clinical narrative: General Rash; Itchiness; possible hives; Redness to Cheeks that were Warm to touch; This spontaneous report was received from a Physician and refers to a 13-year-old male patient.   The patient's medical history was not reported. The patient's concurrent conditions included Environmental allergies. Concomitant therapies were not reported.   On 28-FEB-2025, the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) solution for injection (lot #, dose, route of administration, anatomical location of vaccine and expiration date were not reported) for Prophylaxis.  On 28-FEBB-2025, experienced general rash, itchiness and redness to cheeks that were "warm to touch" after receiving first dose, additionally, he experienced rash and redness approximately one hour after receiving injection. Patient was given a dose of Fexofenadine (ALLEGRA) on the same day. The reporter said that the symptoms continued a second day and was given a second dose of Fexofenadine (ALLEGRA). The reporter stated that on the third day patient came into clinic for consultation and remnants of a rash and "possible hives" were seen. No other findings were notice. At the reporting time, the outcome of the events was unknown.  The causal relationship between the events and Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) was unknown.
Age: 4.0
Vaccine: VARCEL
Symptoms: Expired product administered
Clinical narrative: No additional AE; HCP called in to report that an expired dose of VARIVAX was administered.; This spontaneous report was received from a nurse and refers to a 4-year-old patient of unknown gender.   The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.   On 19-Mar-2025, the patient was vaccinated with an expire dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #X007373, expiration date: 12-Mar-2025) 0.5 mL (strength and anatomical location not provided) for prophylaxis, diluted with sterile diluent (MERCK STERILE DILUENT), (lot #2087420, expiration date: 21-Jan-2027) 0.5 mL for an unknown indication. o symptoms reported. No additional information available
Sex: F
Vaccine: PPV, PPV, PPV
Symptoms: Anti-ganglioside antibody positive, Autoantibody test, CSF glucose normal, CSF neutrophil count increased, CSF protein increased
Clinical narrative: Miller Fisher Syndrome; This literature marketed report was received from the authors in a published literature article, concerning a 70-year-old female patient. Information regarding the patients' concurrent conditions, medical history or concomitant medications was not provided.   On unknown dates, the patient was vaccinated with an unspecified pneumococcal vaccine (Manufacturer unknown) for prophylaxis (strength, route of administration, lot # and expiration date were not reported).  8 days after receiving the vaccine, the patient presented to the emergency room with headache, diplopia, and limb paresthesia. Initial neuroimaging showed white matter disease and segmental occlusion of the distal left vertebral artery with reconstitution. Lumbar puncture (LP) was performed, and cerebrospinal fluid showed elevated WBCs with neutrophil predominance, elevated protein and normal glucose. Additional autoimmune, inflammatory and paraneoplastic workup was sent while broad-spectrum antimicrobial treatment for suspected meningitis was initiated. She was subsequently intubated for worsening encephalopathy and hypoxic, hypercapnic respiratory failure and admitted to the Intensive Care Unit. MRI/MRV Brain was negative. EEG showed Delta- Theta coma. Serial neurological exams revealed coma with ocular square wave jerks. Repeat MRI Brain with and without contrast was suspicious for bilateral hippocampal enhancement thought to be possible brainstem or limbic encephalitis. LP was repeated with resolving pleocytosis, and subsequent exam showed purposeful vertical eye movements. Intravenous immunoglobulin was initiated and GM1 antibody test returned positive, confirming the suspicion of post-PV MF syndrome. The outcome of the event was unknown.   The event was considered related to the pneumococcal vaccine.
Sex: F
Vaccine: PPV, PPV, PPV
Symptoms: CSF white blood cell count increased, Coma, Diplopia, Electroencephalogram abnormal, Encephalopathy
Clinical narrative: Miller Fisher Syndrome; This literature marketed report was received from the authors in a published literature article, concerning a 70-year-old female patient. Information regarding the patients' concurrent conditions, medical history or concomitant medications was not provided.   On unknown dates, the patient was vaccinated with an unspecified pneumococcal vaccine (Manufacturer unknown) for prophylaxis (strength, route of administration, lot # and expiration date were not reported).  8 days after receiving the vaccine, the patient presented to the emergency room with headache, diplopia, and limb paresthesia. Initial neuroimaging showed white matter disease and segmental occlusion of the distal left vertebral artery with reconstitution. Lumbar puncture (LP) was performed, and cerebrospinal fluid showed elevated WBCs with neutrophil predominance, elevated protein and normal glucose. Additional autoimmune, inflammatory and paraneoplastic workup was sent while broad-spectrum antimicrobial treatment for suspected meningitis was initiated. She was subsequently intubated for worsening encephalopathy and hypoxic, hypercapnic respiratory failure and admitted to the Intensive Care Unit. MRI/MRV Brain was negative. EEG showed Delta- Theta coma. Serial neurological exams revealed coma with ocular square wave jerks. Repeat MRI Brain with and without contrast was suspicious for bilateral hippocampal enhancement thought to be possible brainstem or limbic encephalitis. LP was repeated with resolving pleocytosis, and subsequent exam showed purposeful vertical eye movements. Intravenous immunoglobulin was initiated and GM1 antibody test returned positive, confirming the suspicion of post-PV MF syndrome. The outcome of the event was unknown.   The event was considered related to the pneumococcal vaccine.
Sex: F
Vaccine: PPV, PPV, PPV
Symptoms: Endotracheal intubation, Headache, Immunoglobulin therapy, Inflammatory marker test, Intensive care
Clinical narrative: Miller Fisher Syndrome; This literature marketed report was received from the authors in a published literature article, concerning a 70-year-old female patient. Information regarding the patients' concurrent conditions, medical history or concomitant medications was not provided.   On unknown dates, the patient was vaccinated with an unspecified pneumococcal vaccine (Manufacturer unknown) for prophylaxis (strength, route of administration, lot # and expiration date were not reported).  8 days after receiving the vaccine, the patient presented to the emergency room with headache, diplopia, and limb paresthesia. Initial neuroimaging showed white matter disease and segmental occlusion of the distal left vertebral artery with reconstitution. Lumbar puncture (LP) was performed, and cerebrospinal fluid showed elevated WBCs with neutrophil predominance, elevated protein and normal glucose. Additional autoimmune, inflammatory and paraneoplastic workup was sent while broad-spectrum antimicrobial treatment for suspected meningitis was initiated. She was subsequently intubated for worsening encephalopathy and hypoxic, hypercapnic respiratory failure and admitted to the Intensive Care Unit. MRI/MRV Brain was negative. EEG showed Delta- Theta coma. Serial neurological exams revealed coma with ocular square wave jerks. Repeat MRI Brain with and without contrast was suspicious for bilateral hippocampal enhancement thought to be possible brainstem or limbic encephalitis. LP was repeated with resolving pleocytosis, and subsequent exam showed purposeful vertical eye movements. Intravenous immunoglobulin was initiated and GM1 antibody test returned positive, confirming the suspicion of post-PV MF syndrome. The outcome of the event was unknown.   The event was considered related to the pneumococcal vaccine.
Sex: F
Vaccine: PPV, PPV, PPV
Symptoms: Laboratory test, Magnetic resonance imaging head abnormal, Meningitis, Miller Fisher syndrome, Myelofibrosis
Clinical narrative: Miller Fisher Syndrome; This literature marketed report was received from the authors in a published literature article, concerning a 70-year-old female patient. Information regarding the patients' concurrent conditions, medical history or concomitant medications was not provided.   On unknown dates, the patient was vaccinated with an unspecified pneumococcal vaccine (Manufacturer unknown) for prophylaxis (strength, route of administration, lot # and expiration date were not reported).  8 days after receiving the vaccine, the patient presented to the emergency room with headache, diplopia, and limb paresthesia. Initial neuroimaging showed white matter disease and segmental occlusion of the distal left vertebral artery with reconstitution. Lumbar puncture (LP) was performed, and cerebrospinal fluid showed elevated WBCs with neutrophil predominance, elevated protein and normal glucose. Additional autoimmune, inflammatory and paraneoplastic workup was sent while broad-spectrum antimicrobial treatment for suspected meningitis was initiated. She was subsequently intubated for worsening encephalopathy and hypoxic, hypercapnic respiratory failure and admitted to the Intensive Care Unit. MRI/MRV Brain was negative. EEG showed Delta- Theta coma. Serial neurological exams revealed coma with ocular square wave jerks. Repeat MRI Brain with and without contrast was suspicious for bilateral hippocampal enhancement thought to be possible brainstem or limbic encephalitis. LP was repeated with resolving pleocytosis, and subsequent exam showed purposeful vertical eye movements. Intravenous immunoglobulin was initiated and GM1 antibody test returned positive, confirming the suspicion of post-PV MF syndrome. The outcome of the event was unknown.   The event was considered related to the pneumococcal vaccine.
Sex: F
Vaccine: PPV, PPV, PPV
Symptoms: Paraesthesia, Pleocytosis, Respiratory failure, Scan with contrast abnormal, Venogram normal
Clinical narrative: Miller Fisher Syndrome; This literature marketed report was received from the authors in a published literature article, concerning a 70-year-old female patient. Information regarding the patients' concurrent conditions, medical history or concomitant medications was not provided.   On unknown dates, the patient was vaccinated with an unspecified pneumococcal vaccine (Manufacturer unknown) for prophylaxis (strength, route of administration, lot # and expiration date were not reported).  8 days after receiving the vaccine, the patient presented to the emergency room with headache, diplopia, and limb paresthesia. Initial neuroimaging showed white matter disease and segmental occlusion of the distal left vertebral artery with reconstitution. Lumbar puncture (LP) was performed, and cerebrospinal fluid showed elevated WBCs with neutrophil predominance, elevated protein and normal glucose. Additional autoimmune, inflammatory and paraneoplastic workup was sent while broad-spectrum antimicrobial treatment for suspected meningitis was initiated. She was subsequently intubated for worsening encephalopathy and hypoxic, hypercapnic respiratory failure and admitted to the Intensive Care Unit. MRI/MRV Brain was negative. EEG showed Delta- Theta coma. Serial neurological exams revealed coma with ocular square wave jerks. Repeat MRI Brain with and without contrast was suspicious for bilateral hippocampal enhancement thought to be possible brainstem or limbic encephalitis. LP was repeated with resolving pleocytosis, and subsequent exam showed purposeful vertical eye movements. Intravenous immunoglobulin was initiated and GM1 antibody test returned positive, confirming the suspicion of post-PV MF syndrome. The outcome of the event was unknown.   The event was considered related to the pneumococcal vaccine.
Sex: F
Vaccine: PPV, PPV, PPV
Symptoms: Vertebral artery occlusion, White matter lesion
Clinical narrative: Miller Fisher Syndrome; This literature marketed report was received from the authors in a published literature article, concerning a 70-year-old female patient. Information regarding the patients' concurrent conditions, medical history or concomitant medications was not provided.   On unknown dates, the patient was vaccinated with an unspecified pneumococcal vaccine (Manufacturer unknown) for prophylaxis (strength, route of administration, lot # and expiration date were not reported).  8 days after receiving the vaccine, the patient presented to the emergency room with headache, diplopia, and limb paresthesia. Initial neuroimaging showed white matter disease and segmental occlusion of the distal left vertebral artery with reconstitution. Lumbar puncture (LP) was performed, and cerebrospinal fluid showed elevated WBCs with neutrophil predominance, elevated protein and normal glucose. Additional autoimmune, inflammatory and paraneoplastic workup was sent while broad-spectrum antimicrobial treatment for suspected meningitis was initiated. She was subsequently intubated for worsening encephalopathy and hypoxic, hypercapnic respiratory failure and admitted to the Intensive Care Unit. MRI/MRV Brain was negative. EEG showed Delta- Theta coma. Serial neurological exams revealed coma with ocular square wave jerks. Repeat MRI Brain with and without contrast was suspicious for bilateral hippocampal enhancement thought to be possible brainstem or limbic encephalitis. LP was repeated with resolving pleocytosis, and subsequent exam showed purposeful vertical eye movements. Intravenous immunoglobulin was initiated and GM1 antibody test returned positive, confirming the suspicion of post-PV MF syndrome. The outcome of the event was unknown.   The event was considered related to the pneumococcal vaccine.
Sex: M
Vaccine: HPV9, HPV9, HPV9, HPV9
Symptoms: Extra dose administered, No adverse event
Clinical narrative: extra dose administered; No adverse event; This spontaneous report was received from other healthcare professional and refers to a male patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.   On unspecified date, the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (strength, dose, route, anatomical location, lot # and expiration date were not reported) for prophylaxis. On an unknown date, the patient received the second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (strength, dose, route, anatomical location, lot # and expiration date were not reported) for prophylaxis. On an unknown date in 2022, the patient received the third dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (strength, dose, route, anatomical location, lot # and expiration date were not reported) for prophylaxis. On unknown date, the patient's physician recommended patient to receive a booster dose so he recently received one additional dose (fourth) of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (strength, dose, route, anatomical location, lot # and expiration date were not reported) for prophylaxis (extra dose administered). The primary reporter did not think one booster dose would help patient and is asking if patient should receive two more doses of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9).  No adverse event reported.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Sharing Paxlovid; Sharing Paxlovid; This is a spontaneous report received from a Consumer or other non HCP, Program ID.  A female patient received BNT162b2 (BNT162B2 NOS), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 4 (booster), single (Batch/Lot number: unknown), as dose 5 (booster), single (Batch/Lot number: unknown), as dose 6 (booster), single (Batch/Lot number: unknown) and as dose 7 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Sharing Paxlovid". Therapeutic measures were taken as a result of drug ineffective, covid-19 included PAXLOVID. Clinical course: The patient's husband reported that "All 7 of our injections have been Pfizer products. we didn't get the very last updated, maybe that's why we got nailed this time it was pretty bad.".; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500043426 same reporter/product/event, different patients;
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: COVID-19; COVID-19; This is a spontaneous report received from a Consumer or other non HCP, Program ID.  A 68-year-old male patient received BNT162b2 (BNT162B2 NOS), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 4 (booster), single (Batch/Lot number: unknown), as dose 5 (booster), single (Batch/Lot number: unknown), as dose 6 (booster), single (Batch/Lot number: unknown) and as dose 7 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient was taking Paxlovid as treatment. The patient reported that "All 7 of our injections have been Pfizer products. we didn't get the very last updated, maybe that's why we got nailed this time it was pretty bad."
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Erythema
Clinical narrative: 1 cm area of redness and erythema
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Hypoaesthesia
Clinical narrative: patient had facial numbness around cheeks and mouth, patient was monitored for 30 minutes and hydrated with bottled water, still had numbness and went to ER for further checks because numbness was still present but patient reported no additional adverse events
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Joint swelling, Muscle spasms, Pain in extremity
Clinical narrative: Patient experienced leg cramps progressing to extreme leg pain.  Patient went to the emergency room with her husband.  Notes swelling of knee, administered Gabapentin and Norco and released.  Told not to receive the 2nd dose in two months.  Upon checking with patient on 4-11-2025 she was doing much better and pain had resolved.
Age: 69.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Rash, Rash pruritic, Skin exfoliation
Clinical narrative: intensely itchy rash with bumps on left side of face, spreading to left side of neck, lasting 10 days, followed by pealing skin.  two days later, similar reaction on left side of knee, ongoing
Age: 81.0
Sex: M
Vaccine: TDAP
Symptoms: Balance disorder, Fall, Feeling drunk, Gait disturbance
Clinical narrative: Patient called the pharmacy today 4-12-2025 concerned that he had an adverse reaction from the Tdap vaccine he received on 4-11-2025. He said about 2 hours post vaccination he was out in his yard picking up limbs and all at once he became unbalanced and felt like he was drunk. He said he fell 3 times trying staggering to get back to his house. I asked did he hurt himself when he fell and he said no. He said he went inside and sit in his recliner and after about 2 hour he was feeling fine. Patient said he feels fine today as well.
Age: 74.0
Sex: F
Vaccine: RSV, VARZOS
Symptoms: Erythema, Skin irritation, Skin weeping
Clinical narrative: Patient called and stated that she had a red, irritated mark near her navel and that her belly button was oozing a little bit and had an odor.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site rash, Pain in extremity, Sleep disorder
Clinical narrative: Patient Got vaccine 4/10/25 at 11:10am, Woke up on 4/11/25 with red rash around injection site. Pain when lay on arm hard to sleep. Today 4/12/25 Rash about 3-4 inches in diameter circle around injection site. Advised patient to mark rash and watch for change in size, pain, itch or temperature(heat).  Patient will use cool compresses, benadryl, tylenol or ibuprofen as needed and see MD or ED if gets worse.
Age: 60.0
Sex: M
Vaccine: PNC20
Symptoms: Arthralgia, Bone pain, Chills, Hyperhidrosis, Joint noise
Clinical narrative: Shaking fevers (103 f), chills, sweats, severe arthralgias, myalgias, and bone pain. Swollen knees with pain & crepitus.
Age: 60.0
Sex: M
Vaccine: PNC20
Symptoms: Joint swelling, Myalgia, Pyrexia, Tremor
Clinical narrative: Shaking fevers (103 f), chills, sweats, severe arthralgias, myalgias, and bone pain. Swollen knees with pain & crepitus.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Rash morbilliform
Clinical narrative: Fever and diffuse measles like rash. Fever started day after vaccine Tmax 39.2, low grade fevers for 36-48 hours after the high fever. Rash started day 9, worsened throughout the week and resolved day 15 post vaccine.
Age: 55.0
Sex: M
Vaccine: VARZOS
Symptoms: Migraine
Clinical narrative: I have had a migraine headache for 6 days now starting on the second day of getting the vaccine dose.  I have had migraines before but every other time they were gone by the 3rd to 4th day.
Age: 72.0
Sex: F
Vaccine: PNC21, TDAP
Symptoms: Injection site haemorrhage
Clinical narrative: Patient reports to pharmacy that "both vaccines bled, and that I have never had a vaccine that has bled before. It covered both bandages." Patient reported to facility compliance and complaint line.
Age: 79.0
Sex: M
Vaccine: PNC20
Symptoms: Injection site mass, Injection site rash, Rash erythematous
Clinical narrative: Patient came in today 4-12-2025. Patient had red- spotted rash that has been traveling down his left arm where shot was given. Rash does not hurt or itch but patient felt knot. Patient is to follow up with Dr.
Age: 76.0
Sex: F
Vaccine: PNC21
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Hot, red, swollen arm at injection site.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Administered Pediatric COVID-19 vaccine to an adult. Could not reach him to correct error.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Myocardial infarction
Clinical narrative: Death from heart attack.
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Loss of personal independence in daily activities, Pain in extremity, Sleep disorder
Clinical narrative: Patient came in the pharmacy on 4/12/2025 stating that he received the vaccination last month and that his left arm continued to hurt and that the pain extended toward the neck area and this prohibited him from doing normal daily activities and also cause loss of sleep. Patient has been taking aleve over the counter but the pain did not go resolve
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Lymphadenopathy, Vaccination site swelling
Clinical narrative: Swelling in left are and red striations above vaccination site. Swelling in lymph nodes near armpit
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Myocardial infarction
Clinical narrative: Heart Attack
Age: 81.0
Sex: M
Vaccine: VARZOS
Symptoms: Bell's palsy
Clinical narrative: Patient was diagnosed and given treatment for Bell's palsy on 4/13/2025.  Valtrex 1 gram,  t tablet TID for 7 days; prednisone 20 mg 3 tablets QD for 7 days
Age: 71.0
Sex: M
Vaccine: PNC20
Symptoms: No adverse event
Clinical narrative: pt did not have any symptoms since he got the vaccine
Age: 18.0
Sex: F
Vaccine: HEPA, MNQ
Symptoms: Immediate post-injection reaction, Seizure
Clinical narrative: Patient received Havrix vaccine first, in the left arm, then Menquadfi second in the right arm. Immediately after the Menquadfi vaccine was administered, patient started having a seizure. Seizure lasted less than a few minutes, 911 was called, fire department arrived first. Vitals were 86/53 bp and heart rate 60. Patient was taken by ambulance to ER. Patient was alert and able to answer questions. No physical trauma noted.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cancer surgery, Condition aggravated, Immediate post-injection reaction, Influenza like illness, Radiotherapy
Clinical narrative: Flu- like symptoms immediately following injections, RECURRENT CANCER at the same site that was treated with radiation in 1995.  TURBO CANCER after 26 years of remission.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Recurrent cancer
Clinical narrative: Flu- like symptoms immediately following injections, RECURRENT CANCER at the same site that was treated with radiation in 1995.  TURBO CANCER after 26 years of remission.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Condition aggravated, Echocardiogram, Electrocardiogram, Herpes simplex
Clinical narrative: Pericarditis, recurring starting in November 2021 went ER.     Again in 2022, unsure of month, ER treatment. In November of 2023 ER treatment and hospitalization for 4 days.   Other adverse effects include severe worsening of herpes simplex 2 symptoms in frequency, duration and severity. 3 hours after vaccine taken herpes symptoms broke out did not go away for one month additionally since taking the vaccine in 2021 I have had 10 herpes breakouts whereas I had only had 11 instances of herpes breakouts since I first contracted it in 1987.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pericarditis
Clinical narrative: Pericarditis, recurring starting in November 2021 went ER.     Again in 2022, unsure of month, ER treatment. In November of 2023 ER treatment and hospitalization for 4 days.   Other adverse effects include severe worsening of herpes simplex 2 symptoms in frequency, duration and severity. 3 hours after vaccine taken herpes symptoms broke out did not go away for one month additionally since taking the vaccine in 2021 I have had 10 herpes breakouts whereas I had only had 11 instances of herpes breakouts since I first contracted it in 1987.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Abdominal pain upper, Antinuclear antibody positive, Biopsy skin, Blood test
Clinical narrative: I never felt OK after the PFIZER Booster. My condition deteriorated weekly, monthly, now 3.5 years after the shot. Pain all over turned out to be small fiber neuropathy. My stomach started hurting and I've seen many doctors as recently as April 5, 2025; another CT scan. I can't eat with out horrible pain and I'm 111 lbs, down from 140 prior to she booster. I'm a different woman since that booster at pharmacy. I an always dehydrated. Constipation and now the report says my Colon is collapsed. I'll be seeing a GI doctor.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram abdomen, Constipation, Dehydration, General physical health deterioration, Large intestinal obstruction
Clinical narrative: I never felt OK after the PFIZER Booster. My condition deteriorated weekly, monthly, now 3.5 years after the shot. Pain all over turned out to be small fiber neuropathy. My stomach started hurting and I've seen many doctors as recently as April 5, 2025; another CT scan. I can't eat with out horrible pain and I'm 111 lbs, down from 140 prior to she booster. I'm a different woman since that booster at pharmacy. I an always dehydrated. Constipation and now the report says my Colon is collapsed. I'll be seeing a GI doctor.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Neurolysis, Pain, Small fibre neuropathy, Ultrasound abdomen, Weight decreased
Clinical narrative: I never felt OK after the PFIZER Booster. My condition deteriorated weekly, monthly, now 3.5 years after the shot. Pain all over turned out to be small fiber neuropathy. My stomach started hurting and I've seen many doctors as recently as April 5, 2025; another CT scan. I can't eat with out horrible pain and I'm 111 lbs, down from 140 prior to she booster. I'm a different woman since that booster at pharmacy. I an always dehydrated. Constipation and now the report says my Colon is collapsed. I'll be seeing a GI doctor.
Age: 39.0
Sex: F
Vaccine: VARZOS
Symptoms: Wrong product administered
Clinical narrative: Patient received the wrong vaccine. Patient was to receive the MMR vaccine, instead she received Shingrix.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chemotherapy, Coma, Constipation, Death
Clinical narrative: Injection received February 2022. Patient had extreme back pain through December 2022, leaving employment 1/5/2023. Suffered Drop Foot and limited mobility 1/18/2023. Sent to emergency room due to lack of ability to urinate or have bowel movements 1/23/2023. Resulting MRI revealed tumor of the spine. Surgery to remove tumor took place 1/31/2023. Standard of care chemotherapy and radiation took place, followed by inpatient acute rehabilitation. A clinical trial for trial medication ONC201 was started to assist in stopping the cancer. Seizures began 8/31/2024, resulting in Coma for about 5 days. Patient passed away from metastasis to brain 10/15/2024.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Impaired work ability, Magnetic resonance imaging spinal abnormal, Malignant neoplasm of spinal cord, Metastases to central nervous system, Mobility decreased
Clinical narrative: Injection received February 2022. Patient had extreme back pain through December 2022, leaving employment 1/5/2023. Suffered Drop Foot and limited mobility 1/18/2023. Sent to emergency room due to lack of ability to urinate or have bowel movements 1/23/2023. Resulting MRI revealed tumor of the spine. Surgery to remove tumor took place 1/31/2023. Standard of care chemotherapy and radiation took place, followed by inpatient acute rehabilitation. A clinical trial for trial medication ONC201 was started to assist in stopping the cancer. Seizures began 8/31/2024, resulting in Coma for about 5 days. Patient passed away from metastasis to brain 10/15/2024.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Peroneal nerve palsy, Radiotherapy, Seizure, Tumour excision, Urinary retention
Clinical narrative: Injection received February 2022. Patient had extreme back pain through December 2022, leaving employment 1/5/2023. Suffered Drop Foot and limited mobility 1/18/2023. Sent to emergency room due to lack of ability to urinate or have bowel movements 1/23/2023. Resulting MRI revealed tumor of the spine. Surgery to remove tumor took place 1/31/2023. Standard of care chemotherapy and radiation took place, followed by inpatient acute rehabilitation. A clinical trial for trial medication ONC201 was started to assist in stopping the cancer. Seizures began 8/31/2024, resulting in Coma for about 5 days. Patient passed away from metastasis to brain 10/15/2024.
Age: 75.0
Sex: M
Vaccine: VARZOS
Symptoms: Brain fog, Fatigue, Pain in extremity
Clinical narrative: Patient stated he became disoriented with fog brain and very fatigued, arm was sore for 2 weeks
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Back pain, Epstein-Barr virus infection, Epstein-Barr virus test positive, Fatigue
Clinical narrative: Received booster vaccination 2/10/2022. Didn't feel well with migraine headaches, overall weakness and fatigue since injection. Back pain, feverish feeling and throat irritation resulted in urgent care visit June 2023. Bloodwork confirmed reactivation of Epstein-Barr Virus with high serology levels. Suffered syncope with collapse 7/13/2023, with no known cause. Symptoms from EBV persist to date of this report.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Migraine, Pyrexia, Syncope, Throat irritation
Clinical narrative: Received booster vaccination 2/10/2022. Didn't feel well with migraine headaches, overall weakness and fatigue since injection. Back pain, feverish feeling and throat irritation resulted in urgent care visit June 2023. Bloodwork confirmed reactivation of Epstein-Barr Virus with high serology levels. Suffered syncope with collapse 7/13/2023, with no known cause. Symptoms from EBV persist to date of this report.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash, Injection site swelling
Clinical narrative: Swelling at injection site and rash developed  7 days later per patient
Age: 61.0
Sex: F
Vaccine: PNC21
Symptoms: Erythema, Pain in extremity
Clinical narrative: CUSTOMER CAME IN WITH LOCAL REACTION LEFT ARM- SORENESS REDNESS AND PAIN
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time, Alopecia, Antiphospholipid antibodies, Blood glucose fluctuation, Blood thyroid stimulating hormone
Clinical narrative: Bloody noses repeatedly, extensive bruises face, neck, arms, chest, abdomen, back, buttocks, legs.  Bleeding gums while talking, eating or drinking. Bilateral pitting edema lower legs. Hair loss, muscle pains. Blood sugar crashes. Bulging eyes repeatedly.  Racing heart rate.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Brain natriuretic peptide, Contusion, Echocardiogram, Epistaxis, Exophthalmos
Clinical narrative: Bloody noses repeatedly, extensive bruises face, neck, arms, chest, abdomen, back, buttocks, legs.  Bleeding gums while talking, eating or drinking. Bilateral pitting edema lower legs. Hair loss, muscle pains. Blood sugar crashes. Bulging eyes repeatedly.  Racing heart rate.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count, Gingival bleeding, Glycosylated haemoglobin, Metabolic function test, Myalgia
Clinical narrative: Bloody noses repeatedly, extensive bruises face, neck, arms, chest, abdomen, back, buttocks, legs.  Bleeding gums while talking, eating or drinking. Bilateral pitting edema lower legs. Hair loss, muscle pains. Blood sugar crashes. Bulging eyes repeatedly.  Racing heart rate.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema, Palpitations, Platelet function test, Prothrombin level, Rheumatoid factor
Clinical narrative: Bloody noses repeatedly, extensive bruises face, neck, arms, chest, abdomen, back, buttocks, legs.  Bleeding gums while talking, eating or drinking. Bilateral pitting edema lower legs. Hair loss, muscle pains. Blood sugar crashes. Bulging eyes repeatedly.  Racing heart rate.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Thyroxine free, Urine analysis
Clinical narrative: Bloody noses repeatedly, extensive bruises face, neck, arms, chest, abdomen, back, buttocks, legs.  Bleeding gums while talking, eating or drinking. Bilateral pitting edema lower legs. Hair loss, muscle pains. Blood sugar crashes. Bulging eyes repeatedly.  Racing heart rate.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Injection site mass
Clinical narrative: IMMEDIATE LUMP UNDER SKIN AT INJECTION SITE, COLD COMPRESS
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Injection site swelling, Injection site warmth, Pyrexia
Clinical narrative: Patient reported mild fever for more than 1 day but went away after she took some OTC ibuprofen. Her arm got swollen around the site of injection and kept getting bigger. It felt warm to the touch but not very painful. Patient took OTC ibuprofen and cold compress but it still not improved.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Patient reported red and swollen arm. Patient received vaccine on 4/10/25 and reaction progressed. Patient report reaction to pharmacy 4/13/25. I advise patient to try Benadryl for the reaction and to follow up with her md provider.
Age: 1.5
Sex: M
Vaccine: PNC15, VARCEL
Symptoms: Body temperature increased, Decreased appetite, Erythema, Palatal ulcer, Rash
Clinical narrative: 04 April 2025: 18 month old received Varivax (dose 1) and PCV-15 (dose 3)  09 April 2025: T102.8, emesis x 2, rash to neck and back; decreased appetite. Father reported that he had "varicella" 2 weeks ago, was evaluated at another hospital.  10 April 2025: presented to ED, afebrile with exam performed and documented by NP; noted "shallow ulcerations to palate, generalized vesicopustular rash to face, trunk, and extremities, sparing palms and soles". Discharged 10 April 2025 11 April 2025: represented to ED with continued temp of 102, responds to antipyretics and recurs. Evaluated by MD. Parents reported lesions started on back. Lesions have a red base, vesiculopustular, scabbing, pruritic. Decreased appetite. Administered diphenhydramine; one palatal ulcer noted; lesions diffuse over trunk, extremities, face, near eyes, no scleral or conjunctival involvement. Discharged 11 April 2025.  Per my assessment as the hospital epidemiologist, I recommended reporting to VAERS as it is unclear if this is wild-type varicella from exposure to the father or varicella-vaccine associated. No diagnostic testing was done at either ED encounter. PCP declined to complete the VAERS form, as by report, he did not feel that the child's lesions and ED presentations x 2 were vaccine associated.
Age: 1.5
Sex: M
Vaccine: PNC15, VARCEL
Symptoms: Rash pustular, Scab, Skin lesion, Vomiting
Clinical narrative: 04 April 2025: 18 month old received Varivax (dose 1) and PCV-15 (dose 3)  09 April 2025: T102.8, emesis x 2, rash to neck and back; decreased appetite. Father reported that he had "varicella" 2 weeks ago, was evaluated at another hospital.  10 April 2025: presented to ED, afebrile with exam performed and documented by NP; noted "shallow ulcerations to palate, generalized vesicopustular rash to face, trunk, and extremities, sparing palms and soles". Discharged 10 April 2025 11 April 2025: represented to ED with continued temp of 102, responds to antipyretics and recurs. Evaluated by MD. Parents reported lesions started on back. Lesions have a red base, vesiculopustular, scabbing, pruritic. Decreased appetite. Administered diphenhydramine; one palatal ulcer noted; lesions diffuse over trunk, extremities, face, near eyes, no scleral or conjunctival involvement. Discharged 11 April 2025.  Per my assessment as the hospital epidemiologist, I recommended reporting to VAERS as it is unclear if this is wild-type varicella from exposure to the father or varicella-vaccine associated. No diagnostic testing was done at either ED encounter. PCP declined to complete the VAERS form, as by report, he did not feel that the child's lesions and ED presentations x 2 were vaccine associated.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Magnetic resonance imaging, Pain in extremity
Clinical narrative: injected and developed severe left arm pain afterwards that persisted for up to greater than 1 month
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Allergic respiratory symptom, Pyrexia, Viral test
Clinical narrative: Fever, "allergy symptoms"
Age: 0.42
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Product preparation issue
Clinical narrative: Vaccine was not reconstituted. Only liquid component of Dtap-IPV was administered to patient.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Cellulitis, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: cellulitis-Medium, Additional Details: patient recieved cellulitis
Age: 54.0
Sex: F
Vaccine: PNC21
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Fever-Medium, Additional Details: patient reports rash at injection site that is red and spreading down the arm as time goes on
Age: 56.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Rash
Clinical narrative: Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Additional Details: Warm to the touch large red spot where vaccine was given. she said it first appeared several days after the vaccine.
Age: 66.0
Sex: M
Vaccine: RSV
Symptoms: Pruritus, Rash
Clinical narrative: Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash Generalized-Mild, Additional Details: he has mild rash all over his body and itching, Other Vaccines:  VaccineTypeBrand: Covid; Manufacturer: moderna; LotNumber: 3044060; Route: im; BodySite: left deltoid; Dose: 00; VaxDate: 03/30/2025, VaccineTypeBrand: Tdap; Manufacturer: glaxosmithkline; LotNumber: ak334; Route: im; BodySite: Left Deltoid; Dose: 00; VaxDate: 03/30/2025, VaccineTypeBrand: Shingrix; Manufacturer: glaxosmithkline; LotNumber: 3x97j; Route: im; BodySite: Right Deltoid; Dose: 00; VaxDate: 03/30/2025
Age: 66.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Medium
Age: 86.0
Sex: F
Vaccine: TDAP
Symptoms: Flushing, Hyperhidrosis, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium
Age: 86.0
Sex: F
Vaccine: TDAP
Symptoms: Pruritus, Pyrexia
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Injection site pain, Pyrexia
Clinical narrative: Site: Pain at Injection Site-Mild, Systemic: Fever-Medium, Systemic: Headache-Medium, Additional Details: Patient had high fever later in the evening of administration, which became mild next day (~100 degrees F). Also had bad migraine for 2 days unrelieved by OTC meds
Age: 64.0
Sex: F
Vaccine: PNC21
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Site: Bruising at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Anxiety, Cellulitis, Fear, Injection site erythema, Injection site pain
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Fever-Severe, Additional Details: patient reported pain, inflammation, redness at the injection side. patient saw her primary physician and then went to the hospital. Patient was diagnosed with cellulitis, patient has extreme fear and anxiety getting vaccines in the future due to her experience
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site swelling, Pyrexia
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Fever-Severe, Additional Details: patient reported pain, inflammation, redness at the injection side. patient saw her primary physician and then went to the hospital. Patient was diagnosed with cellulitis, patient has extreme fear and anxiety getting vaccines in the future due to her experience
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Rash
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Rash Generalized-Mild
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Lethargy, Pyrexia, Rash
Clinical narrative: Systemic: Allergic: Rash Generalized-Mild, Systemic: Chills-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fever-Mild, Additional Details: Patient developed rash on body 5 days after vaccine. Other symptoms subsided. still has rash. not itchy. calling dermatologist this week
Age: 72.0
Sex: F
Vaccine: FLU4
Symptoms: Joint injury
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Age: 45.0
Sex: F
Vaccine: TDAP
Symptoms: Hypoaesthesia, Injection site erythema, Injection site pain, Neuralgia
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Additional Details: PT CALLED AND STATED THAT SHE IS EXPERIENCING ADVERSE REACTIONS FROM TEH TDAP RECEIVED ON 3/1/2025 - NUMBNESS IN THMB & ARM.  NERVE PAIN OR ARM  (LEFT SIEDE).
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Eye swelling, Fatigue, Flushing
Clinical narrative: Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Nausea-Medium, Systemic: Unable to Sleep-Medium, Systemic: Weakness-Medium
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Hyperhidrosis, Insomnia, Lethargy, Mouth swelling
Clinical narrative: Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Nausea-Medium, Systemic: Unable to Sleep-Medium, Systemic: Weakness-Medium
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Nausea, Pain, Pruritus, Pyrexia, Swelling face
Clinical narrative: Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Nausea-Medium, Systemic: Unable to Sleep-Medium, Systemic: Weakness-Medium
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Swollen tongue
Clinical narrative: Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Nausea-Medium, Systemic: Unable to Sleep-Medium, Systemic: Weakness-Medium
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: Itchness swelling and pain at site of injection about 3 to 4 in diameter
Age: 46.0
Sex: F
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Systemic: Allergic: Rash Generalized-Mild, Additional Details: full body rash, not limiting activity. no issue at injection site
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Pruritus, Rash
Clinical narrative: Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Eye swelling, Injection site swelling, Mouth swelling, Swelling face, Swollen tongue
Clinical narrative: Site: Swelling at Injection Site-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Severe
Age: 49.0
Sex: F
Vaccine: TDAP
Symptoms: Joint injury
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-